EUCTR2006-001614-33-IT进行中（未招募）不适用
Appraisal of the role of the 68Ga-DOTANOC in the diagnostic by Positron emission tomography (PET) in the study of human tumors of neuroendocrine derivation - ND
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2007年9月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adult subjects (age >18 years) of both sex bearers of tumors of neuroendocrine derivation, joints for specialized appraisal to the Policlinico S.Orsola-Malpighi.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •subjects not in a position to meaning and of wanting, the healthy volunteers, the minors, the women in state of pregnancy, the women during breast-feeding, and patients in emergency situations.
研究者
相似试验
进行中（未招募）
不适用
se of new radiopharmaceutical (callede 68-Ga-DOTANOC) for diagnosis of particolar tumorsTumors od neuroendrocrine originMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsEUCTR2011-001724-38-ITOSPEDALE SACRO CUORE-DON CALABRIA
进行中（未招募）
不适用
A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.Patients with neuroendocrine tumors, who are going to be diagnosed/evaluated with 68Ga-DOTA-TATE PET/CT instead of standard OctreoscanMedDRA version: 14.1Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 100000004864EUCTR2012-004313-13-SESkåne University Hospital, Dept of Oncology450
进行中（未招募）
不适用
se of 68Ga-DOTA-NOC for the evaluation of patients with Idiopathic pulmonary fibrosisSTUDY CODE: 68Ga-DOTA-NOC/ILD 01/2008 - 68Ga-DOTA-NOC/ILD01/2008EUCTR2008-007168-40-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中（未招募）
1 期
Safety and tolerability of an injectable diagnostic radiopharmaceutical (68Ga-DOTATOC) in patients with proven gastro-entero-pancreatic neuroendocrine tumors.Patients with proven gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs)MedDRA version: 17.0 Level: LLT Classification code 10062476 Term: Neuroendocrine tumor System Organ Class: 100000004864EUCTR2014-002741-21-GBAdvanced Accelerator Applications SA20
进行中（未招募）
不适用
68Ga-DOTANOC as a PET tool to diagnose nueroendocrine tumors - NDStudy of tumor neuroendocrin originEUCTR2010-022975-67-ITAZIENDA U.L.S.S. N.8 DI ASOLO